|SAME AS||SAME AS S00270-B|
|COSPNSR||Zebrowski, Ceretto, McDonough, Jaffee, Simotas, Millman, Tenney, Markey, Lavine, Stec, Sepulveda, Roberts, Paulin, Quart, Bronson, Steck, Skoufis, Kellner, Brook-Krasny, Gabryszak, Abinanti, Lentol, Benedetto, Rosenthal, Skartados, Otis, Gottfried, Lalor, Tedisco|
|MLTSPNSR||Arroyo, Aubry, Barclay, Blankenbush, Brennan, Buchwald, Clark, Colton, Cook, Crespo, Crouch, Curran, Dinowitz, Duprey, Farrell, Finch, Fitzpatrick, Giglio, Hevesi, Hooper, Lopez P, Lupardo, Lupinacci, McDonald, McLaughlin, Montesano, Mosley, Oaks, O'Donnell, Palmesano, Perry, Ra, Raia, Rivera, Robinson, Rodriguez, Simanowitz, Walter|
|Amd S2500-a, Pub Health L|
|Requires facilities to perform pulse oximetry screening on newborns.|
Go to top
NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
BILL NUMBER: A2316B SPONSOR: Gunther (MS)
TITLE OF BILL: An act to amend the public health law, in relation to requiring facilities to screen newborns for critical congenital heart defects through pulse oximetry screening   PURPOSE OR GENERAL IDEA OF BILL: Requires facilities to perform pulse oximetry screening on newborns for critical congenital heart defects   JUSTIFICATION: This bill requires each birthing facility in the state of New York be required to perform a pulse oximetry screening for critical congenital heart defects (CCHDs). For newborns, pulse oximetry screening involves taping a small sensor to a newborn's foot while the sensor beams red light through the foot to measure how much oxygen is in the blood, pulse oximetry screening is effective at detecting CHDs that may otherwise go undetected by current screening methods. Pulse oximetry screenings are non-invasive, painless, and take approximately one minute to perform. According to the United States Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children, congenital heart disease affects approximately seven to nine of every 1,000 live births in the United States and Europe; the federal Centers for Disease Control and Prevention states that CHD is the leading cause of infant death due to birth defects, and that about 4,800 babies born every year have CCHDs. Current methods used to detect CHDs include prenatal ultrasound screening and repeated clinical examinations; howev- er, prenatal ultrasound screenings, alone, identify less than half of all CHD cases. Many newborn lives could potentially be saved by requir- ing birthing facilities to incorporate pulse oximetry screening as a method for early detection of CHDs in conjunction with current CHD screening methods.   PRIOR LEGISLATIVE HISTORY: 2011-12; A7941 Held in Health/S6726 Passed Senate   FISCAL IMPLICATIONS: None to the State.   EFFECTIVE DATE: This act shall take effect on the one hundred eightieth day after it shall have become a law; provided, however, that effective immediately, the addition, amendment and/or repeal of any rule or regulation neces- sary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date.
Go to top
STATE OF NEW YORK ________________________________________________________________________ 2316--B 2013-2014 Regular Sessions IN ASSEMBLY January 14, 2013 ___________ Introduced by M. of A. GUNTHER, ZEBROWSKI, CERETTO, McDONOUGH, JAFFEE, SIMOTAS, MILLMAN, TENNEY, MARKEY, MAISEL, LAVINE, STEC, SEPULVEDA, ROBERTS, PAULIN, QUART, BRONSON, STECK, ESPINAL, SKOUFIS, KELLNER, BROOK-KRASNY, GABRYSZAK, ABINANTI, LENTOL, BENEDETTO -- Multi-Spon- sored by -- M. of A. ARROYO, AUBRY, BARCLAY, BLANKENBUSH, BRENNAN, BUCHWALD, CLARK, COLTON, COOK, CRESPO, CROUCH, CURRAN, DINOWITZ, DUPREY, FARRELL, FINCH, FITZPATRICK, HEVESI, HOOPER, P. LOPEZ, LUPAR- DO, LUPINACCI, McDONALD, McLAUGHLIN, MONTESANO, MOSLEY, OAKS, O'DONNELL, PALMESANO, PERRY, RAIA, RIVERA, ROBINSON, RODRIGUEZ, SIMA- NOWITZ, WALTER -- read once and referred to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- again reported from said committee with amendments, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to requiring facili- ties to screen newborns for critical congenital heart defects through pulse oximetry screening The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Legislative intent. Congenital heart defects (CHDs) are 2 structural abnormalities of the heart that are present at birth; CHDs 3 range in severity from simple problems such as holes between chambers of 4 the heart, to severe malformations, such as the complete absence of one 5 or more chambers or valves; critical CHDs (CCHDs) are a subset of CHDs 6 that cause severe and life-threatening symptoms which require inter- 7 vention within the first days, weeks or months of life. 8 According to the United States Secretary of Health and Human Services' 9 Advisory Committee on Heritable Disorders in Newborns and Children, 10 congenital heart disease affects approximately seven to nine of every 11 1,000 live births in the United States and Europe. The federal Centers 12 for Disease Control and Prevention states that CHD is the leading cause EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD01366-12-3A. 2316--B 2 1 of infant death due to birth defects and that about forty-eight hundred 2 babies born each year have one of seven CCHDs. 3 Current methods for detecting CHDs generally include prenatal ultra- 4 sound screening and repeated clinical examinations; while prenatal 5 ultrasound screenings can detect some major CHDs, these screenings, 6 alone, identify less than half of all CHD cases. CCHD cases are often 7 missed during routine clinical exams performed prior to a newborn's 8 discharge from a birthing facility. 9 Pulse oximetry is a non-invasive test that estimates the percentage of 10 hemoglobin in blood that is saturated with oxygen. When performed on a 11 newborn a minimum of 24 hours after birth, pulse oximetry screening is 12 often more effective at detecting critical, life-threatening CHDs which 13 otherwise go undetected by current screening methods. Newborns with 14 abnormal pulse oximetry results require immediate confirmatory testing 15 and intervention or a referral to an appropriate health care provider 16 for confirmatory testing and follow-up care, based on the recommendation 17 of the treating health care provider. 18 The legislature finds and declares that many newborn lives could 19 potentially be saved by earlier detection and treatment of CHDs if 20 birthing facilities in the state of New York were required to perform 21 this simple, non-invasive newborn screening in conjunction with current 22 CHD screening methods. 23 § 2. Subdivision (a) of section 2500-a of the public health law, as 24 amended by chapter 863 of the laws of 1986, is amended to read as 25 follows: 26 (a) It shall be the duty of the administrative officer or other person 27 in charge of each institution caring for infants twenty-eight days or 28 less of age and the person required in pursuance of the provisions of 29 section forty-one hundred thirty of this chapter to register the birth 30 of a child, to cause to have administered to every such infant or child 31 in its or his care a test for phenylketonuria, homozygous sickle cell 32 disease, hypothyroidism, branched-chain ketonuria, galactosemia, homo- 33 cystinuria, critical congenital heart defects through pulse oximetry 34 screening, and such other diseases and conditions as may from time to 35 time be designated by the commissioner in accordance with rules or regu- 36 lations prescribed by the commissioner. Testing, the recording of the 37 results of such tests, tracking, follow-up reviews and educational 38 activities shall be performed at such times and in such manner as may be 39 prescribed by the commissioner. The commissioner shall promulgate regu- 40 lations setting forth the manner in which information describing the 41 purposes of the requirements of this section shall be disseminated to 42 parents or a guardian of the infant tested. 43 § 3. This act shall take effect on the one hundred eightieth day after 44 it shall have become a law; provided, however, that effective immediate- 45 ly, the addition, amendment and/or repeal of any rule or regulation 46 necessary for the implementation of this act on its effective date are 47 authorized and directed to be made and completed on or before such 48 effective date.